Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
1985-12-20
pubmed:abstractText
Antibody to actin isolated from the rabbit thymus gland exerted a dose-dependent inhibitory effect upon the proliferation of an Epstein-Barr virus-transformed human B cell line, LA350. Purified rabbit thymus actin specifically reversed the inhibitory effect of antibody by competing with surface actin on LA350. For example, LA350 proliferation at 48 hr was inhibited 90% at a 1:10 antibody dilution (p less than 0.001) but only 48% and 20% in the presence of 190 and 380 micrograms/ml of rabbit thymus actin, respectively (p less than 0.001 for reversal). Cyclic AMP augmented in a dose-related fashion the inhibitory effects of antibody, e.g., a 1:20 dilution of antibody inhibited 10, 19, 41, and 67% at 0.0, 0.5, 1.0, and 2.0 mM cAMP, respectively (p less than 0.001). We conclude that anti-actin antibody recognizes surface actin on a human B cell line and produces a functional inhibition of proliferation by a process that is augmented by cAMP.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0006-291X
pubmed:author
pubmed:issnType
Print
pubmed:day
30
pubmed:volume
132
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
837-43
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed:year
1985
pubmed:articleTitle
Anti-rabbit thymus actin antibody inhibits proliferation of Epstein-Barr virus-transformed human B cell line LA350: augmentation by cyclic AMP.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't